Corbus Pharmaceuticals Holdings, Inc.CRBPNASDAQ
Loading
Operating Expenses Over TimeExpanding
Percentile Rank92
3Y CAGR+36.8%
5Y CAGR-7.6%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
+36.8%/yr
vs -14.2%/yr prior
5Y CAGR
-7.6%/yr
Recent acceleration
Acceleration
+51.0pp
Accelerating
Percentile
P92
Near historical high
vs 5Y Ago
0.7x
Contraction
Streak
3 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $85.31M | +77.3% |
| 2024 | $48.12M | +6.8% |
| 2023 | $45.08M | +35.2% |
| 2022 | $33.35M | -39.6% |
| 2021 | $55.23M | -56.4% |
| 2020 | $126.75M | +436.1% |
| 2019 | $23.64M | -61.6% |
| 2018 | $61.57M | +75.9% |
| 2017 | $35.00M | +59.9% |
| 2016 | $21.90M | - |